Person attributes
Other attributes
Dr. Samarth Kulkarni has served as Chief Executive Officer of CRISPR Therapuetics since December 2017. He joined CRISPR in August 2015 in the early stages of the company as Chief Business Officer, and then served as President and Chief Business Officer starting May 2017. Prior to joining our company, he was a Partner at McKinsey & Company, where he had a role in the Pharmaceutical and Medical products practice and co-led the biotech practice. He received a Ph.D. in Bioengineering and Nanotechnology from the University of Washington and a B. Tech. from the Indian Institute of Technology. While at the University of Washington, he conducted research in the delivery of biological drugs and in the field of molecular diagnostics.